• Nenhum resultado encontrado

Arq. NeuroPsiquiatr. vol.75 número11

N/A
N/A
Protected

Academic year: 2018

Share "Arq. NeuroPsiquiatr. vol.75 número11"

Copied!
1
0
0

Texto

(1)

837

https://doi.org/10.1590/0004-282X20170161

IMAGES IN NEUROLOGY

Terson’s syndrome in the context of

intracranial hemorrhage

SíndromeTerson no contexto das hemorragias intracranianas

Ana Paula Alves Fonseca

1

, Marcos Rosa Júnior

2

A 62-year-old man was admitted with a hypertensive

emer-gency, anisocoria and decreased level of consciousness. he CT

scan showed a hemorrhage in the brainstem and an intraocular

hemorrhage (Figure), consistent with Terson’s syndrome, a con

-dition that is classically characterized as a vitreous hemorrhage

secondary to a subarachnoid hemorrhage. However, it can also

be considered as a traumatic hemorrhage and, more rarely, as an

intraparenchymal hemorrhage. he etiology has been attributed

to a rapid increase in intracranial pressure, resulting in reduced

retinal venous drainage and leading to vitreous bleeding. Terson’s

syndrome is associated a high rate of morbidity and mortality

not only in patients with subarachnoid hemorrhage

1,2,3,4,5

.

1Universidade Federal do Espírito Santo, Departamento de Radiologia, Vitória ES, Brasil;

2Universidade Federal do Espírito Santo, Departamento de Neurorradiologia, Vitória ES, Brasil.

Correspondence: Marcos Rosa Júnior; Departamento de Neurorradiologia da UFES / Centro de Ciências da Saúde; Avenida Marechal Campos, 1355; 29041-295 Vitória ES, Brasil; E-mail: marcosrosajr@hotmail.com

Conflict of interest: There is no conflict of interest to declare.

Received 24 September 2016; Accepted 11 August 2017.

Figure.

Computed tomography (CT) showed a hemorrhage in the brainstem and in the vermis of the cerebellum (black arrow in A)

and an intraocular hemorrhage in the right eye (white arrow in B), which appeared as spontaneously hyperdense areas on the CT.

A

B

References

1. Joswig H, Epprecht L, Valmaggia C, Leschka S,

Hildebrandt G, Fournier JY et al. Terson syndrome in aneurysmal subarachnoid hemorrhage-its relation to intracranial pressure, admission factors, and clinical outcome. Acta Neurochir (Wien). 2016;158(6):1027-36. https://doi.org/10.1007/s00701-016-2766-8

2. Czorlich P, Skevas C, Knospe V, Vettorazzi E, Richard G,

Wagenfeld L et al. Terson syndrome in subarachnoid hemorrhage, intracerebral hemorrhage, and traumatic brain injury. Neurosurg Rev. 2015;38(1):129-36. https://doi.org/10.1007/s10143-014-0564-4

3. Takkar A, Kesav P, Lal V, Gupta A. Teaching neuroImages: Terson

syndrome in cortical venous sinus thrombosis. Neurology. 2013;81(6):e40-1. https://doi.org/ 10. 1212/ WNL. 0b013e31829e6f13

4. Kim HS, Lee SW, Sung SK, Seo EK. Terson syndrome caused

by intraventricular hemorrhage associated with moyamoya disease. J Korean Neurosurg Soc. 2012;51(6):367-9. https://doi.org/10.3340/jkns.2012.51.6.367

5. Kapoor S. Terson syndrome: an often overlooked complication

Referências

Documentos relacionados

This study described the scores of the sleep apnea screening questionnaire – STOP-BANG – in patients after a stroke, and correlated the indings with sleep quality measured by the

dystrophy, Becker muscular dystrophy, intermediate pheno- type dystrophinopathy, and female dystrophinopathy car - riers); 3) facioscapulohumeral muscular dystrophy; 4) limb

Conclusion: The procedure using the ICBN as a sensory donor restores good intensity of sensation and shows good results in location of perception in patients with complete

In conclusion, the minimally-invasive technique presented has advantages that include reduced cutaneous-muscular inci - sion, small craniotomy size, a cylindrical

Objective: To evaluate whether the use of a drain and/or the number of burr holes for treatment of CSDH modiies the rates of recurrence and complications.. Methods: A

Hereditary “pure” spastic paraplegia: a clinical and genetic study of 22 families. Salinas S, Proukakis C, Crosby A,

Eficacy of a soft hand brace and a wrist splint for carpal tunnel syndrome: a randomized controlled study. Acta

Mary Broadfoot Walker was a Scottish physician who, in 1935, described in great detail the effect of an anticholinesterase drug (physostigmine) on the signs and symptoms of